TR200200725T2 - Anyonik amino asit bazlı yüzey aktif maddeler. - Google Patents

Anyonik amino asit bazlı yüzey aktif maddeler.

Info

Publication number
TR200200725T2
TR200200725T2 TR2002/00725T TR200200725T TR200200725T2 TR 200200725 T2 TR200200725 T2 TR 200200725T2 TR 2002/00725 T TR2002/00725 T TR 2002/00725T TR 200200725 T TR200200725 T TR 200200725T TR 200200725 T2 TR200200725 T2 TR 200200725T2
Authority
TR
Turkey
Prior art keywords
amino acid
based surfactants
acid based
anionic amino
polymers
Prior art date
Application number
TR2002/00725T
Other languages
English (en)
Inventor
J. Castillo Ernesto
Howard Gerson Steven
Wehsin Han Wesley
Original Assignee
Alcon Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories, Inc. filed Critical Alcon Laboratories, Inc.
Publication of TR200200725T2 publication Critical patent/TR200200725T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En az bir akif bilesen, bir katyonik koruyucu ve karboksivinil polimerler, iksantan zamki, polistiren sülfonik asit polimerleri ve katyonik degisim reçineleri gibi bir anyonik polielektrolit içeren topikal olarak uygulanabilir farmasötik bilesimlerde anti-mikrobik etkinligi arttirmak için anyonik amino asit bazli yüzey aktif maddeler kullanilmistir.
TR2002/00725T 1999-09-21 2000-09-11 Anyonik amino asit bazlı yüzey aktif maddeler. TR200200725T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/399,698 US6146622A (en) 1998-10-27 1999-09-21 Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions

Publications (1)

Publication Number Publication Date
TR200200725T2 true TR200200725T2 (tr) 2002-05-21

Family

ID=23580626

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00725T TR200200725T2 (tr) 1999-09-21 2000-09-11 Anyonik amino asit bazlı yüzey aktif maddeler.

Country Status (13)

Country Link
US (1) US6146622A (tr)
EP (1) EP1214095A1 (tr)
JP (1) JP2003509475A (tr)
CN (1) CN1374873A (tr)
AR (1) AR025712A1 (tr)
AU (1) AU7363800A (tr)
BR (1) BR0014129A (tr)
CA (1) CA2383589A1 (tr)
MX (1) MXPA02003083A (tr)
PL (1) PL354364A1 (tr)
TR (1) TR200200725T2 (tr)
WO (1) WO2001021210A1 (tr)
ZA (1) ZA200201697B (tr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444710B1 (en) 1998-10-27 2002-09-03 Alcon Manufacturing, Ltd. Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
US6290946B1 (en) * 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
ATE291913T1 (de) * 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
JP2003004992A (ja) * 2001-06-25 2003-01-08 Matsushita Electric Ind Co Ltd 光送受信モジュールとその製造方法
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
EP1285579B1 (en) * 2001-08-21 2005-11-02 Ajinomoto Co., Inc. Bactericidal guanidine derivatives, dermally applicable composition, washing composition, and antibacterial fibre aggregate
US7030149B2 (en) 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
NZ537594A (en) * 2002-07-22 2008-05-30 Genzyme Corp Poly (potassium and sodium styrene sulfonate), its manufacture and its uses
KR101120660B1 (ko) 2005-12-21 2012-03-16 주식회사 엘지생활건강 알파-하이드록시 에시드 및 에테르계 계면활성제를포함하는 화장료 조성물
US20070282044A1 (en) * 2006-05-31 2007-12-06 Robert John Cavanaugh Concentrated fluoropolymer dispersions stabilized with anionic polyelectrolyte dispersing agents
EP1920760A1 (fr) * 2006-11-10 2008-05-14 L'Oréal Composition cosmétique comprenant un composé choisi parmi les sels et dérivés d'aminoacides
ES2394130T3 (es) * 2007-11-30 2013-01-22 Toltec Pharmaceuticals, Llc Composiciones y métodos para tratar infecciones vaginales y biopelículas vaginales patógenas
GB0800788D0 (en) * 2008-01-16 2008-02-27 Glaxo Group Ltd Niovel formulation
JP2010063762A (ja) * 2008-09-12 2010-03-25 Yoshiharu Masui 抗菌消臭剤
WO2010151660A1 (en) * 2009-06-24 2010-12-29 Modular Genetics, Inc. Engineered microorganisms and methods of use
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
BR112015012443A2 (pt) 2012-11-29 2017-07-11 Unilever Nv composição de limpeza, método de limpeza do corpo humano, uso da composição e método para prover limpeza
WO2017044366A1 (en) 2015-09-11 2017-03-16 Dow Global Technologies Llc Polyalkoxy fatty compound
US10647782B2 (en) 2015-09-11 2020-05-12 DDP Specialty Electronic Materials US, Inc. Polyalkoxy fatty compound
CN108066283B (zh) * 2017-12-28 2020-03-24 兆科(广州)眼科药物有限公司 一种盐酸左倍他洛尔滴眼液的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275503A (en) * 1964-08-26 1966-09-27 Patterson Co C Method for the protection of loci susceptible to the growth of undesired microorganisms
US4380637A (en) * 1978-11-30 1983-04-19 Johnson & Johnson/Mona Industries, Inc. Imidazoline phosphobetaines
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
GB2172298B (en) * 1985-03-01 1988-11-23 Procter & Gamble Mild detergent mousse
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US5000868A (en) * 1987-04-03 1991-03-19 Wittpenn Jr John R Surfactant compositions
US5093126A (en) * 1987-09-26 1992-03-03 Alcon Laboratories, Inc. Glaucoma formulations comprising an anionic, polysulfonic acid polymer having mucomimetic properties and a polystyrene sulfonic polymer
US5520920A (en) * 1992-08-28 1996-05-28 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
US5529712A (en) * 1993-03-30 1996-06-25 Ajinomoto Co., Inc. Detergent composition
US5504113A (en) * 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
US5536305A (en) * 1994-06-08 1996-07-16 Yu; Bing Low leaching compositions for wood
BR9508088A (pt) * 1994-06-20 1997-08-12 Unilever Nv Composição de limpeza antimicrobiana processo para desinfetar superfícies não vivas e uso em um processo para a preparação de uma coposição desinfetante
US5494937A (en) * 1994-07-22 1996-02-27 Alcon Laboratories, Inc. Saline solution for treating contact lenses
WO1996003158A1 (en) * 1994-07-22 1996-02-08 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US5641480A (en) * 1994-12-08 1997-06-24 Lever Brothers Company, Division Of Conopco, Inc. Hair care compositions comprising heteroatom containing alkyl aldonamide compounds
DK1124582T3 (da) * 1998-10-27 2004-03-22 Alcon Mfg Ltd Konserveringssystem til topisk indgivelige farmaceutiske præparater

Also Published As

Publication number Publication date
JP2003509475A (ja) 2003-03-11
PL354364A1 (en) 2004-01-12
EP1214095A1 (en) 2002-06-19
US6146622A (en) 2000-11-14
WO2001021210A1 (en) 2001-03-29
AU7363800A (en) 2001-04-24
CA2383589A1 (en) 2001-03-29
BR0014129A (pt) 2002-05-21
AR025712A1 (es) 2002-12-11
CN1374873A (zh) 2002-10-16
ZA200201697B (en) 2003-04-30
MXPA02003083A (es) 2002-09-30

Similar Documents

Publication Publication Date Title
TR200200725T2 (tr) Anyonik amino asit bazlı yüzey aktif maddeler.
PT991407E (pt) Estabilizacao de benzimidazoles sensiveis a acidos com combinacoes de amino/ciclodextrinas
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
MEP39108A (en) Pharmaceutical composition
BR0002285A (pt) Formulações tópicas
ATE275378T1 (de) Wässrige kosmetische gele
IT1294760B1 (it) Procedimento per la preparazione di compresse farmaceutiche in grado di cedere,secondo schemi predeterminabili, principi attivi poco
DE60108412D1 (de) Schnell wirkende mikrobizide lotion mit verbesserter wirksamkeit
ATE546135T1 (de) Hyaluronsäure-nanopartikel
EP0835655A4 (en) Antibacterial/bactericidal/antiseptic agent, dermatologic preparation, and detergent composition
TR200003108T2 (tr) İlaç kompozisyonları
PT1267932E (pt) Combinacoes de substancias activas anti-infecciosas e sua utilizacao para o tratamento topico de micoses das unhas dos pes e das maos
NO20010863D0 (no) Nye orale formuleringer for 5-HT4-agonister eller - antagonister
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
ITMI20000095A0 (it) Cerotto per la somministrazione locale e transdermica di principi attivi dotati di gruppi anionici ed elettronattrattori
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
MX9305230A (es) Utilizacion de ciertos surfactantes anionicos para mejorarla efectividad antimicrobiana de composiciones oftalmicas.
HUP0001486A2 (hu) Nimeszulidot tartalmazó gélformájú helyileg alkalmazható gyógyszerkészítmény, valamint eljárás ilyen előállítására
CA2352915A1 (en) Pharmaceutical compositions containing mupirocin
RU96101865A (ru) Дезинфицирующий состав "септабик-20-в"
TR200200724T2 (tr) Cilde sürülebilen farmasötik bileşimlerin antimikrobik etkisinin arttırılması için yağlı asit/amino asit sabunlarının kullanımı
NO20045700L (no) Orale farmasoytiske preparater som innbefatter ionebytterharpikser med aktiv substanstilsetning og pseudoplastiske geldannende fortykningsmidler
PT1347765E (pt) Formulacoes dermatologicas